Sheehan Treacey E, Kumar Ponni A, Hood David A
School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E968-74. doi: 10.1152/ajpendo.00478.2003. Epub 2004 Feb 17.
The influence of thyroid hormone (T(3)) on respiration is partly mediated via its effect on the cytochrome c oxidase (COX) enzyme, a multi-subunit complex within the mitochondrial respiratory chain. We compared the expression of COX subunits I, III, Vb, and VIc and thyroid receptors (TR)alpha1 and TRbeta1 with functional changes in COX activity in tissues that possess high oxidative capacities. In response to 5 days of T(3) treatment, TRbeta1 increased 1.6-fold in liver, whereas TRalpha1 remained unchanged. T(3) also induced concomitant increases in the protein and mRNA expression of nuclear-encoded subunit COX Vb in liver, matched by a 1.3-fold increase in binding to a putative thyroid response element (TRE) within the COX Vb promoter in liver, suggesting transcriptional regulation. In contrast, T(3) had no effect on COX Vb expression in heart. T(3) produced a significant increase in COX III mRNA in liver but decreased COX III mRNA in heart. These changes were matched by parallel alterations in mitochondrial transcription factor A expression in both tissues. In contrast, COX I protein increased in both liver and heart 1.7- and 1.5-fold (P < 0.05), respectively. These changes in COX I closely paralleled the T(3)-induced increases in COX activity observed in both of these tissues. In liver, T(3) induced a coordinated increase in the expression of the nuclear (COX Vb) and mitochondrial (COX I) genomes at the protein level. However, in heart, the main effect of T(3) was restricted to the expression of mitochondrial DNA subunits. Thus our data suggest that T(3) regulates the expression of COX subunits by both transcriptional and posttranscriptional mechanisms. The nature of this regulation differs between tissues possessing a high mitochondrial content, like liver and heart.
甲状腺激素(T(3))对呼吸的影响部分是通过其对细胞色素c氧化酶(COX)的作用介导的,COX是线粒体呼吸链中的一种多亚基复合物。我们比较了具有高氧化能力的组织中COX亚基I、III、Vb和VIc以及甲状腺受体(TR)α1和TRβ1的表达与COX活性的功能变化。在接受5天T(3)治疗后,肝脏中TRβ1增加了1.6倍,而TRα1保持不变。T(3)还诱导肝脏中核编码亚基COX Vb的蛋白质和mRNA表达同时增加,与之相匹配的是肝脏中COX Vb启动子内与假定甲状腺反应元件(TRE)结合增加了1.3倍,提示存在转录调控。相比之下,T(3)对心脏中COX Vb的表达没有影响。T(3)使肝脏中COX III mRNA显著增加,但使心脏中COX III mRNA减少。这些变化与两个组织中线粒体转录因子A表达的平行改变相匹配。相比之下,肝脏和心脏中COX I蛋白分别增加了1.7倍和1.5倍(P < 0.05)。COX I的这些变化与在这两个组织中观察到的T(3)诱导的COX活性增加密切平行。在肝脏中,T(3)在蛋白质水平上诱导核基因组(COX Vb)和线粒体基因组(COX I)表达的协同增加。然而,在心脏中,T(3)的主要作用仅限于线粒体DNA亚基的表达。因此,我们的数据表明,T(3)通过转录和转录后机制调节COX亚基的表达。这种调节的性质在具有高线粒体含量的组织(如肝脏和心脏)之间有所不同。